Monkeypox screening

Monkeypox Microchapters
Home
Patient Info
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes of Monkeypox
Differentiating Monkeypox from other Diseases
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms
Physical Examination
Lab Tests
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Monkeypox screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Monkeypox screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Monkeypox screening
CDC on Monkeypox screening
Monkeypox screening in the news
Blogs on Monkeypox screening
Directions to Hospitals Treating Monkeypox
Risk calculators and risk factors for Monkeypox screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Bassel Almarie, M.D.

Overview

Currently, there are no established screening programs or guidelines for monkeypox in the Americas, Europe, or MENA "Middle East and North Africa" region.

Screening

• Monkeypox has been periodically identified in very small numbers in non-endemic regions.
• As of June 13, 2022, no screening measures were recommended in the Americas, Europe, or MENA "Middle East and North Africa" region.
• As a response to the 2022 global outbreak, the Department of Disease Control in Thailand took precautionary measures, screening travelers arriving into Thailand international airports. The screening targets arrivals from countries where monkeypox cases have been reported.